Baxter (NYSE:BAX) said today that it inked a partnership deal with Biomérieux looking to develop biomarkers to identify acute kidney injury. The partnership was announced at the International Symposium on Intensive Care and Emergency Medicine, Deerfield, Ill.-based Baxter said. Both companies said they hope to develop the biomarkers to help rapidly identify and inform treatment of acute […]
Baxter cleared from DoJ antitrust saline probe
Baxter (NYSE:BAX) said yesterday that it has been cleared from a U.S. Dept. of Justice antitrust probe, launched in 2017, investigating companies that market intravenous saline solutions. The probe came as hospitals endured a shortage of intravenous saline solutions, which are used to hydrate hospital patients. The shortage dates back to late 2013, after drugmakers told […]
Baxter acquires software developer True Process
Baxter (NYSE:BAX) said last week that it acquired healthcare software developer True Process. The company’s Vines software platform is designed for bedside data collection and normalization, according to a report from BizTimes. Founder Todd Dunsirn, who reportedly left the firm after the acquisition closed, told BizTimes that the company’s software aims to connect the various devices […]
Baxter launches on-demand peritoneal dialysis solution device trial
Baxter (NYSE:BAX) said yesterday that it launched an FDA-cleared clinical trial of its on-demand peritoneal dialysis solution generation system intended to allow patients to make peritoneal dialysis solutions in small batches at home. The system is designed to use a small water filtration device, concentrates and Deerfield, Ill.-based Baxter’s Amia automated peritoneal dialysis system to turn a […]
Analyst downgrades pressure medtech stocks
Several medical device companies took hits yesterday after analysts on Wall Street downgraded their stocks, on a day when the major market indices each closed up a hair, and even medtech firms that enjoyed upgrades came under pressure. Globus Medical (NYSE:GMED) suffered the most after Morgan Stanley analyst David Lewis cut his rating on the stock from […]
Senseonics CFO Elsey to retire | Personnel Moves – December 4, 2018
Senseonics (NYSE:SENS) said yesterday that its CFO R. Elsey is retiring for the company, and that it has begun searching for a permanent replacement. The Germantown, Md.-based company said that Elsey will stay on until a replacement is appointed, and remain on in an advisory role through to the completion of the company’s 2018 fiscal […]
Baxter expands share repurchase program to $3.4B
Baxter (NYSE:BAX) said yesterday that it expanded its share purchase program to $3.4 billion. The Deerfield, Ill.-based company approved a $2 billion increase in authorization for the company’s existing share repurchase plan. Baxter also declared a quarterly cash dividend of 19¢ per share of common stock to stockholders as of Dec 3, payable on Jan. 2, of […]
Baxter touts Hemopatch, Floseal study results
Baxter (NYSE:BAX) today presented results from studies of its Hemopatch and Floseal products, touting reductions in costs and hospital stays in both trials. Results from studies of the devices were presented this week at the International Society for Pharmacoeconomics and Outcomes Research Europe 2018 meeting, the Chicago-based company said. In a retrospective observational analysis exploring pancreaticoduodenectomies […]
Baxter dips on Q3 sales miss
Baxter (NYSE:BAX) shares slipped today in pre-market trading after the healthcare giant posted third-quarter sales that missed the consensus forecast on Wall Street and cut its sales outlook for the rest of the year. Chicago-area Baxter posted profits of $544 million, or $1 even per share, on sales of $2.77 billion for the three months ended […]
Baxter wins CE Mark for PrisMax continuous renal replacement system, TherMax blood warmer
Baxter (NYSE:BAX) said today that it won CE Mark approval in the European Union for its PrisMax continuous renal replacement system and TherMax blood warmer. The newly cleared PrisMax system is the company’s next-gen renal replacement and organ support therapy tech, and is intended to supply a range of extracorporeal therapies to remove waste products, excess […]
Baxter, Mayo Clinic ink collab deal to develop US-based renal care center
Baxter (NYSE:BAX) said today that it inked a collaborative deal with the Mayo Clinic to develop a new renal care center of excellence in the US. The new renal care center will be located at the Mayo Clinic’s dialysis center in Jacksonville, Fla., Baxter said, and will integrate Baxter’s Renal Care Services clinical service model and […]
- 1
- 2
- 3
- …
- 27
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube